Anxiety with Depressed Mood in General Practice: A survey of 3,000 Patients treated with Benzoctamine: A Report of a Monitored Release Study

Abstract

A total of 3,000 patients in general practice, with a diagnosis of moderate to severe anxiety with depressive overtones were treated with benzoctamine 10 mg tid for two weeks.

During this period 75 % of the group obtained symptomatic relief, and 45 % were symptom free after two weeks.

The profile of patients responding significantly well to this treatment was studied in detail.

In this group of patients the drug was well tolerated, 11 % of the patients reporting no side effects. Drowsiness was the most commonly reported adverse reaction with an incidence of 9 %.